Additionally, an increasing trend in lymphocyte count throughout disease course is observed among survivors of initial COVID-19 infection, while non-survivors maintained lower lymphocyte count [ [27] , [28] ].
← all excerpts
Effect of thymalfasin (Thymosin-α-1) on reversing lymphocytopenia among patients with COVID-19
1
—
—